Exane Derivatives’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-30
| Closed | -$430 | – | 913 |
|
|
2022
Q1 | $430 | Buy |
+30
| New | +$430 | ﹤0.01% | 881 |
|
|
2021
Q4 | – | Sell |
-30
| Closed | -$491 | – | 953 |
|
|
2021
Q3 | $491 | Hold |
30
| – | – | ﹤0.01% | 921 |
|
|
2021
Q2 | $503 | Hold |
30
| – | – | ﹤0.01% | 922 |
|
|
2021
Q1 | $548 | Hold |
30
| – | – | ﹤0.01% | 770 |
|
|
2020
Q4 | $546 | Hold |
30
| – | – | ﹤0.01% | 720 |
|
|
2020
Q3 | $535 | Hold |
30
| – | – | ﹤0.01% | 645 |
|
|
2020
Q2 | $538 | Hold |
30
| – | – | ﹤0.01% | 586 |
|
|
2020
Q1 | $455 | Hold |
30
| – | – | ﹤0.01% | 586 |
|
|
2019
Q4 | $600 | Hold |
30
| – | – | ﹤0.01% | 574 |
|
|
2019
Q3 | $516 | Hold |
30
| – | – | ﹤0.01% | 552 |
|
|
2019
Q2 | $531 | Hold |
30
| – | – | ﹤0.01% | 569 |
|
|
2019
Q1 | $611 | Buy |
+30
| New | +$611 | ﹤0.01% | 505 |
|